GB9114493D0 - Drug delivery system for administering growth factors - Google Patents

Drug delivery system for administering growth factors

Info

Publication number
GB9114493D0
GB9114493D0 GB919114493A GB9114493A GB9114493D0 GB 9114493 D0 GB9114493 D0 GB 9114493D0 GB 919114493 A GB919114493 A GB 919114493A GB 9114493 A GB9114493 A GB 9114493A GB 9114493 D0 GB9114493 D0 GB 9114493D0
Authority
GB
United Kingdom
Prior art keywords
delivery system
drug delivery
growth factors
administering growth
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB919114493A
Other versions
GB2245831A (en
GB2245831B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Publication of GB9114493D0 publication Critical patent/GB9114493D0/en
Publication of GB2245831A publication Critical patent/GB2245831A/en
Application granted granted Critical
Publication of GB2245831B publication Critical patent/GB2245831B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB9114493A 1990-07-05 1991-07-04 Drug delivery system for administering growth factors Expired - Fee Related GB2245831B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014871A GB9014871D0 (en) 1990-07-05 1990-07-05 Drug delivery system for administering growth factor

Publications (3)

Publication Number Publication Date
GB9114493D0 true GB9114493D0 (en) 1991-08-21
GB2245831A GB2245831A (en) 1992-01-15
GB2245831B GB2245831B (en) 1994-03-23

Family

ID=10678678

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909014871A Pending GB9014871D0 (en) 1990-07-05 1990-07-05 Drug delivery system for administering growth factor
GB9114493A Expired - Fee Related GB2245831B (en) 1990-07-05 1991-07-04 Drug delivery system for administering growth factors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB909014871A Pending GB9014871D0 (en) 1990-07-05 1990-07-05 Drug delivery system for administering growth factor

Country Status (4)

Country Link
JP (1) JPH04279530A (en)
DE (1) DE4121891A1 (en)
GB (2) GB9014871D0 (en)
IT (1) IT1248543B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352589A (en) * 1988-09-16 1994-10-04 Farmitalia Carlo Erba S.R.L. Deletion mutant of basic fibroblast growth factor and production thereof
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
DE69427908T2 (en) 1993-05-31 2001-11-22 Kaken Pharmaceutical Co., Ltd. A GEL PREPARATION MADE FROM CROSSLINKED GELATINE, CONTAINING A BASIC GROWTH FACTOR FOR FIBROBLASTS
AUPM572294A0 (en) * 1994-05-18 1994-06-09 Vaccine Technologies Pty. Ltd. Delivery vehicle for bioactive molecule
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
WO2000045792A1 (en) * 1999-02-03 2000-08-10 Powderject Research Limited Hydrogel particle formulations
JP4565691B2 (en) * 2000-02-28 2010-10-20 株式会社Ｐｈｇ Sustained release substrate for heparin-binding growth factor and heparin-binding growth factor sustained-release agent
KR100720056B1 (en) * 2005-10-06 2007-05-18 (주) 차바이오텍 A Method for producing microsphere coated with nanoparticle containing growth factor and the using method for neuronal differentiation thereby
CN101143894A (en) * 2007-06-22 2008-03-19 中国药科大学 Highly effective polypeptide for inhibiting angiogenesis, physical chemistry modifying method and application thereof
EP2680827B1 (en) * 2011-03-04 2020-01-08 Institut National de la Santé et de la Recherche Médicale Particles containing a growth factor, and uses thereof
TW201932124A (en) * 2018-01-18 2019-08-16 近鎰生技股份有限公司 Hemostatic material, preparation method thereof and pharmaceutical composition containing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor

Also Published As

Publication number Publication date
JPH04279530A (en) 1992-10-05
IT1248543B (en) 1995-01-19
GB2245831A (en) 1992-01-15
ITMI911741A0 (en) 1991-06-25
ITMI911741A1 (en) 1992-12-25
GB2245831B (en) 1994-03-23
GB9014871D0 (en) 1990-08-22
DE4121891A1 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
US5525634B1 (en) Colonic drug delivery system
GB8712176D0 (en) Drug delivery system
GB2185397B (en) Drug delivery system
ZA87737B (en) Drug delivery system
ZA918526B (en) Drug delivery system and method
AU4989993A (en) Drug delivery system
EP0246819A3 (en) Pulsatile drug delivery system
ZA909894B (en) Multi-unit pulsatile delivery system
EP0275213A3 (en) Medication infusion system
AU660290B2 (en) Multiple drug delivery system
GB2245831B (en) Drug delivery system for administering growth factors
GB9226691D0 (en) Dental active delivery system
GB9325330D0 (en) Fluorocyclodextrin drug delivery system
GB9404293D0 (en) Drug delivery system
GB2292887B (en) Drug delivery system
GB9023664D0 (en) Microrabricated in-vivo drug delivery system
ZA897603B (en) Novel drug delivery system
EP0408019A3 (en) Pharmaceutical active derivative delivery systems
IL100147A0 (en) Pharmaceutical delivery system
IE893139L (en) Controlled drug delivery
IE893875L (en) Prefilled syringe delivery system
IL80330A0 (en) Drug delivery system
GB8616617D0 (en) Drug delivery system
AU4275589A (en) Novel drug delivery system
AU3211193A (en) Drug delivery system

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20000704